|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
34,850,000 |
Market
Cap: |
9.17(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.1389 - $0.3069 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Applied Molecular Transport is a clinical-stage biopharmaceutical company utilizing its proprietary technology platform to design and develop a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Co. has two oral biologics in clinical development. Co.'s product candidate, AMT-101, is in Phase 2 development for patients with ulcerative colitis and related inflammatory indications. Co.'s second product candidate, AMT-126 is in Phase 1 development for diseases related to intestinal epithelium barrier function defects.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
150,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$149,635 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
1,085,151 |
1,117,888 |
Total Sell Value |
$0 |
$0 |
$175,700 |
$195,444 |
Total People Sold |
0 |
0 |
3 |
6 |
Total Sell Transactions |
0 |
0 |
8 |
25 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kanwar Bittoo |
Chief Medical Officer |
|
2023-03-01 |
4 |
S |
$0.50 |
$270 |
D/D |
(539) |
78,005 |
|
45% |
|
Rich Douglas A. |
Chief Technical Officer |
|
2023-03-01 |
4 |
S |
$0.50 |
$241 |
D/D |
(482) |
49,316 |
|
45% |
|
Mahmood Tahir Ph.d. |
Chief Executive Officer |
|
2023-03-01 |
4 |
S |
$0.50 |
$901 |
D/D |
(1,802) |
73,626 |
|
45% |
|
Mrsny Randall Ph.d. |
Director |
|
2022-12-02 |
4 |
S |
$1.05 |
$439 |
D/D |
(418) |
21,136 |
|
78% |
|
Kanwar Bittoo |
Chief Medical Officer |
|
2022-12-02 |
4 |
S |
$1.05 |
$3,663 |
D/D |
(3,488) |
78,544 |
|
78% |
|
Hants Brandon |
CFO |
|
2022-12-02 |
4 |
S |
$1.05 |
$2,057 |
D/D |
(1,959) |
32,819 |
|
78% |
|
Rich Douglas A. |
Chief Technical Officer |
|
2022-12-02 |
4 |
S |
$1.05 |
$4,441 |
D/D |
(4,229) |
49,798 |
|
78% |
|
Cross Shawn |
President & COO |
|
2022-12-02 |
4 |
S |
$1.05 |
$4,088 |
D/D |
(3,893) |
61,090 |
|
78% |
|
Mahmood Tahir Ph.d. |
Chief Executive Officer |
|
2022-12-02 |
4 |
S |
$0.00 |
$0 |
D/D |
(1,772) |
75,428 |
|
78% |
|
Vandevender Aaron |
Director |
|
2022-11-28 |
4 |
B |
$1.00 |
$49,975 |
D/D |
50,000 |
212,659 |
2.39 |
-71% |
|
Vandevender Aaron |
Director |
|
2022-11-25 |
4 |
B |
$1.00 |
$99,660 |
D/D |
100,000 |
162,659 |
2.39 |
-74% |
|
Mahmood Tahir Ph.d. |
Chief Executive Officer |
|
2022-09-01 |
4 |
S |
$1.42 |
$2,447 |
D/D |
(1,723) |
74,154 |
|
54% |
|
Hants Brandon |
CFO |
|
2022-09-01 |
4 |
S |
$1.42 |
$656 |
D/D |
(462) |
34,774 |
|
54% |
|
Cross Shawn |
President & COO |
|
2022-09-01 |
4 |
S |
$1.42 |
$1,255 |
D/D |
(884) |
64,983 |
|
54% |
|
Mrsny Randall Ph.d. |
Director |
|
2022-09-01 |
4 |
S |
$1.42 |
$574 |
D/D |
(404) |
21,554 |
|
54% |
|
Kanwar Bittoo |
Chief Medical Officer |
|
2022-09-01 |
4 |
S |
$1.42 |
$714 |
D/D |
(503) |
82,028 |
|
54% |
|
Rich Douglas A. |
Chief Technical Officer |
|
2022-09-01 |
4 |
S |
$1.42 |
$636 |
D/D |
(448) |
54,027 |
|
54% |
|
Mrsny Randall Ph.d. |
Director |
|
2022-06-02 |
4 |
S |
$3.04 |
$1,193 |
D/D |
(392) |
20,039 |
|
- |
|
Kanwar Bittoo |
Chief Medical Officer |
|
2022-06-02 |
4 |
S |
$3.04 |
$6,681 |
D/D |
(2,196) |
80,612 |
|
- |
|
Hants Brandon |
CFO |
|
2022-06-02 |
4 |
S |
$3.04 |
$3,414 |
D/D |
(1,122) |
33,263 |
|
- |
|
Cross Shawn |
President & COO |
|
2022-06-02 |
4 |
S |
$3.04 |
$6,590 |
D/D |
(2,166) |
65,867 |
|
- |
|
Mahmood Tahir Ph.d. |
Chief Executive Officer |
|
2022-06-02 |
4 |
S |
$3.04 |
$5,151 |
D/D |
(1,693) |
74,925 |
|
- |
|
Rich Douglas A. |
Chief Technical Officer |
|
2022-06-02 |
4 |
S |
$3.04 |
$7,917 |
D/D |
(2,602) |
54,475 |
|
- |
|
Mrsny Randall Ph.d. |
Director |
|
2022-06-01 |
4 |
S |
$2.97 |
$947 |
D/D |
(319) |
20,431 |
|
- |
|
Kanwar Bittoo |
Chief Medical Officer |
|
2022-06-01 |
4 |
S |
$2.97 |
$5,318 |
D/D |
(1,792) |
82,808 |
|
- |
|
106 Records found
|
|
Page 2 of 5 |
|
|